| Literature DB >> 16554135 |
Masahito Miyazaki1, Hiromichi Ito, Takahiko Saijo, Kenji Mori, Shoji Kagami, Yasuhiro Kuroda.
Abstract
We treated three boys with attention deficit/hyperactivity disorder (ADHD) associated with giant somatosensory evoked potentials (SEP). All responded well to extended-release valproate (EVA), a gamma-aminobutyric acid (GABA) enhancer. Improvement particularly involved hyperactivity and impulsivity. When methylphenidate previously was administered to two patients, symptoms worsened. EVA therefore may be preferable for ADHD with giant SEP.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16554135 DOI： 10.1016/j.braindev.2006.01.005
Source DB: PubMed Journal: Brain Dev ISSN： 0387-7604 Impact factor: 1.961